Hepatitis C Virus (HCV) Market Explored by Koncept Analytics in Its New Topical Report Available at MarketPublishers.com
22 Mar 2016 • by Natalie Aster
LONDON – Hepatitis C Virus (HCV) is recognised as an infection, which spreads via infected blood transfusions and also poorly sterilised medical devices and affects the liver. The number of patients suffering from HCV has increased considerably because the symptoms of the disease take time to be diagnosed, before a patient progresses to a clinically visible liver damage. Up to 2010, there was no any proper therapy for HCV, but then introduction of Viekira Pak by AbbVie as well as Harvoni and Sovaldi by Gilead has improved the situation.
The HCV maker is likely to grow in the near future spurred by increasing patient pool, medical reimbursement, introduction of new drugs, treatment of warehoused patients, better regimens and increased competition, among other important growth drivers. However, the HCV market growth could be hindered by price cuttings, increasing demand for reimbursement amid patients, certain risks associated with drug development and also some regulatory risks.
Some of important developments of the HCV industry include introduction of such products as Harvoni, Viekira Pak and Sovaldi, the launch of the interferon-free regimen and the newly identified and diagnosed patients.
Details on the performance of the worldwide HCV market can be found in the in-demand topical research report “Global Hepatitis C Virus (HCV) Market Report: 2016 Edition” prepared by Koncept Analytics. This research study delves deep into the world HCV market landscape, examines the market dynamics, uncovers data on the market performance, pinpoints the top market trends and analyses key factors shaping the market. The report profiles the leading market players and explores the competitive environment. Furthermore, possible ways of the global HCV market development in the years to come are discussed in the report.
Global Hepatitis C Virus (HCV) Market Report: 2016 Edition
Published: March, 2016
Price: US$ 800.00
Other topical reports by Koncept Analytics are available in this catalogue.